Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caelyx, Cyclophosphamide, and Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00258960Phase 2Completed
- Sponsor
- GEICAM
- Start
- Feb 2006
- Primary completion
- Jul 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in breast cancer, sponsored by GEICAM. Started Feb 2006; status: completed.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00258960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258960.